231 related articles for article (PubMed ID: 31351484)
1. Tau and atrophy: domain-specific relationships with cognition.
Digma LA; Madsen JR; Reas ET; Dale AM; Brewer JB; Banks SJ;
Alzheimers Res Ther; 2019 Jul; 11(1):65. PubMed ID: 31351484
[TBL] [Abstract][Full Text] [Related]
2. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
[TBL] [Abstract][Full Text] [Related]
3. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
[TBL] [Abstract][Full Text] [Related]
4. Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study.
Xu G; Zheng S; Zhu Z; Yu X; Jiang J; Jiang J; Chu Z;
Ann Nucl Med; 2020 Nov; 34(11):815-823. PubMed ID: 32785820
[TBL] [Abstract][Full Text] [Related]
5. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
[TBL] [Abstract][Full Text] [Related]
6. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
7. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
[TBL] [Abstract][Full Text] [Related]
9. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
[TBL] [Abstract][Full Text] [Related]
10. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults.
Harrison TM; Du R; Klencklen G; Baker SL; Jagust WJ
Alzheimers Dement; 2021 Jul; 17(7):1085-1096. PubMed ID: 33325068
[TBL] [Abstract][Full Text] [Related]
12. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
Tanner JA; Iaccarino L; Edwards L; Asken BM; Gorno-Tempini ML; Kramer JH; Pham J; Perry DC; Possin K; Malpetti M; Mellinger T; Miller BL; Miller Z; Mundada NS; Rosen HJ; Soleimani-Meigooni DN; Strom A; La Joie R; Rabinovici GD
Brain; 2022 Dec; 145(12):4489-4505. PubMed ID: 35762829
[TBL] [Abstract][Full Text] [Related]
13. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.
Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M
Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977
[TBL] [Abstract][Full Text] [Related]
14. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
[TBL] [Abstract][Full Text] [Related]
15. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
16. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
Colato E; Chiotis K; Ferreira D; Mazrina MS; Lemoine L; Mohanty R; Westman E; Nordberg A; Rodriguez-Vieitez E;
J Alzheimers Dis; 2021; 84(1):103-117. PubMed ID: 34511502
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal tau accumulation and atrophy in aging and alzheimer disease.
Harrison TM; La Joie R; Maass A; Baker SL; Swinnerton K; Fenton L; Mellinger TJ; Edwards L; Pham J; Miller BL; Rabinovici GD; Jagust WJ
Ann Neurol; 2019 Feb; 85(2):229-240. PubMed ID: 30597624
[TBL] [Abstract][Full Text] [Related]
20. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
